Cited by 117Pharmaceutical Practices and Patient OutcomesDementia and Cognitive Impairment ResearchIntensive Care Unit Cognitive Disorders

Cognitive improvement following benzodiazepine discontinuation in elderly nursing home residents

Salzman, Carl, Fisher, Janina, Nobel, Kenneth, Glassman, Randy, Wolfson, Abbie, Kelley, Margaret·1992·International Journal of Geriatric Psychiatry

Abstract

In a controlled study, benzodiazepine treatment was gradually discontinued from a group of elderly nursing home residents. In comparison with similar residents who continued on benzodiazepines, measures of memory and cognitive functioning showed significant improvement following discontinuance. There was no associated increase in anxiety, agitation, or sleeplessness. These data are consistent with previous observations suggesting that benzodiazepines impair cognitive function in the elderly and further indicate that such impairment is reversible upon benzodiazepine discontinuance.

Integrity signals

Registry

Crossref · 10.1002/gps.930070205

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Salzman et al. (1992) reported that cognitive impairment in nursing home residents was reversed after withdrawal.

    “Salzman, Fisher, Nobel, and Glassman (1992) reported that cognitive impairment observed in their samples of 13 nursing home residents was reversed after withdrawal as compared to the 12 residents who did not withdraw.”

    From Persistence of cognitive effects after withdrawal from long-term benzodiazepine use: a meta-analysis (2004) · cites this paper as Salzman, Fisher, Nobel, and Glassman (1992)

Cited by

Sorted by citations

Authors
Salzman, C., Fisher, J., Nobel, K., Glassman, R., Wolfson, A., & Kelley, M.
Affiliations
Harvard University (US)
Venue
International Journal of Geriatric Psychiatry
Publisher
Wiley
Published
1992-02
Volume
7
Issue
2
Pages
89-93
ISSN
  • 0885-6230 (ISSN-L)
  • 1099-1166
OpenAlex
W2092914302
Cited by
117
References
0
Citations by year
2025: 4 · 2023: 2 · 2022: 1 · 2021: 1 · 2020: 9 · 2019: 2 · 2018: 2 · 2017: 2 · 2016: 2 · 2015: 4 · 2014: 8 · 2013: 4 · 2012: 4
FWCI
4.26
Type
journal article
Language
en
Open access
closed
Locations
International Journal of Geriatric Psychiatry (publishedVersion)
Topics
  • Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Intensive Care Unit Cognitive Disorders
Keywords
benzodiazepines, benzodiazepine discontinuation, cognitive impairment, memory, older adults, nursing home residents, anxiety, agitation, insomnia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review